About this Journal Submit a Manuscript Table of Contents
Oxidative Medicine and Cellular Longevity
Volume 2013 (2013), Article ID 308358, 8 pages
http://dx.doi.org/10.1155/2013/308358
Research Article

Influence of Block of NF-Kappa B Signaling Pathway on Oxidative Stress in the Liver Homogenates

1Experimental and Clinical Physiology, Department of Cardiovascular Physiology, Medical University of Lodz, 6/8 Mazowiecka Street, 92-215 Lodz, Poland
2Department of Biochemical Pharmacy, Department of Pharmacy, Medical University of Lodz, 1 Muszynskiego Street, 91-151 Lodz, Poland
3Laboratory of Molecular Diagnostic and Pharmacogenomics, Department of Biochemical Pharmacy, Medical University of Lodz, 1 Muszynskiego Street, 91-151 Lodz, Poland

Received 27 October 2012; Revised 18 February 2013; Accepted 19 February 2013

Academic Editor: Ron Kohen

Copyright © 2013 Paulina Kleniewska et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Yanagisawa, H. Kurihara, S. Kimura et al., “A novel potent vasoconstrictor peptide produced by vascular endothelial cells,” Nature, vol. 332, no. 6163, pp. 411–415, 1988. View at Scopus
  2. K. J. Dammanahalli and Z. Sun, “Endothelins and NADPH oxidases in the cardiovascular system,” Clinical and Experimental Pharmacology and Physiology, vol. 35, no. 1, pp. 2–6, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. A. K. Khimji and D. C. Rockey, “Endothelin—biology and disease,” Cellular Signalling, vol. 22, no. 11, pp. 1615–1625, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. B. Vollmar and M. D. Menger, “The hepatic microcirculation: mechanistic contributions and therapeutic targets in liver injury and repair,” Physiological Reviews, vol. 89, no. 4, pp. 1269–1339, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Sakurai, M. Yanagisawa, Y. Takuwa et al., “Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor,” Nature, vol. 348, no. 6303, pp. 732–735, 1990. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Taddei, A. Virdis, L. Ghiadoni, I. Sudano, A. Magagna, and A. Salvetti, “Role of endothelin in the control of peripheral vascular tone in human hypertension,” Heart Failure Reviews, vol. 6, no. 4, pp. 277–285, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Yokomori, M. Oda, Y. Yasogawa et al., “Enhanced expression of endothelin B receptor at protein and gene levels in human cirrhotic liver,” The American Journal of Pathology, vol. 159, no. 4, pp. 1353–1362, 2001. View at Scopus
  8. C. Housset, D. C. Rockey, and D. M. Bissell, “Endothelin receptors in rat liver: lipocytes as a contractile target for endothelin 1,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 20, pp. 9266–9270, 1993. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Gabriel, R. H. Kuddus, A. S. Rao, W. D. Watkins, and C. R. Gandhi, “Superoxide-induced changes in endothelin (ET) receptors in hepatic stellate cells,” Journal of Hepatology, vol. 29, no. 4, pp. 614–627, 1998. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Pinzani, S. Milani, R. de Franco et al., “Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells,” Gastroenterology, vol. 110, no. 2, pp. 534–548, 1996. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Moller, C. Emmeluth, and J. H. Henriksen, “Elevated circulating plasma endothelin-1 concentrations in cirrhosis,” Journal of Hepatology, vol. 19, no. 2, pp. 285–290, 1993. View at Publisher · View at Google Scholar · View at Scopus
  12. I. Alam, N. M. Bass, P. Bacchetti, L. Gee, and D. C. Rockey, “Hepatic tissue endothelin-1 levels in chronic liver disease correlate with disease severity and ascites,” The American Journal of Gastroenterology, vol. 95, no. 1, pp. 199–203, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Huguet, A. Gavelli, and S. Bona, “Hepatic resection with ischemia of the liver exceeding one hour,” Journal of the American College of Surgeons, vol. 178, no. 5, pp. 454–458, 1994. View at Scopus
  14. S. Francque, W. Laleman, L. Verbeke et al., “Increased intrahepatic resistance in severe steatosis: endothelial dysfunction, vasoconstrictor overproduction and altered microvascular architecture,” Laboratory Investigation, vol. 92, no. 10, pp. 1428–1439, 2012. View at Publisher · View at Google Scholar
  15. C. R. Gandhi, L. A. Sproat, and V. M. Subbotin, “Increased hepatic endothelin-1 levels and endothelins receptor density in cirrhotic rats,” Life Sciences, vol. 58, no. 1, pp. 55–62, 1996. View at Publisher · View at Google Scholar · View at Scopus
  16. D. C. Rockey, L. Fouassier, J. J. Chung et al., “Cellular localization of endothelin-1 and increased production in liver injury in the rat: potential for autocrine and paracrine effects on stellate cells,” Hepatology, vol. 27, no. 2, pp. 472–480, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Shao and D. C. Rockey, “Effects of endothelins on hepatic stellate cell synthesis of endothelin-1 during hepatic wound healing,” Journal of Cellular Physiology, vol. 191, no. 3, pp. 342–350, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Pinzani and F. Marra, “Cytokine receptors and signaling in hepatic stellate cells,” Seminars in Liver Disease, vol. 21, no. 3, pp. 397–416, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. D. C. Rockey, “Characterization of endothelin receptors mediating rat hepatic stellate cell contraction,” Biochemical and Biophysical Research Communications, vol. 207, no. 2, pp. 725–731, 1995. View at Publisher · View at Google Scholar · View at Scopus
  20. D. C. Rockey and R. A. Weisiger, “Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver: implications for regulation of portal pressure and resistance,” Hepatology, vol. 24, no. 1, pp. 233–240, 1996. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Jaeschke and A. Farhood, “Kupffer cell activation after no-flow ischemia versus hemorrhagic shock,” Free Radical Biology and Medicine, vol. 33, no. 2, pp. 210–219, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Bauer, J. X. Zhang, I. Bauer, and M. G. Clemens, “ET-1 induced alterations of hepatic microcirculation: sinusoidal and extrasinusoidal sites of action,” The American Journal of Physiology, vol. 267, no. 1, pp. G143–G149, 1994. View at Scopus
  23. A. Khimji and D. C. Rockey, “Endothelin and hepatic wound healing,” Pharmacological Research, vol. 63, no. 6, pp. 512–518, 2011. View at Publisher · View at Google Scholar
  24. S. Sriram, D. Subramanian, R. Sathiakumar et al., “Modulation of reactive oxygen species in skeletal muscle by myostatin is mediated through NF-κB,” Aging Cell, vol. 10, no. 6, pp. 931–948, 2011. View at Publisher · View at Google Scholar
  25. J. G. Lunz III, H. Tsuji, I. Nozaki, N. Murase, and A. J. Demetris, “An inhibitor of cyclin-dependent kinase, stress-induced p21 Waf-1/Cip-1, mediates hepatocyte mito-inhibition during the evolution of cirrhosis,” Hepatology, vol. 41, no. 6, pp. 1262–1271, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. M. A. O'Reilly, “Redox activation of p21Cip1/WAF1/Sdi1: a multifunctional regulator of cell survival and death,” Antioxidants and Redox Signaling, vol. 7, no. 1-2, pp. 108–118, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. W. S. Yang, J. W. Chang, N. J. Han, and S. K. Park, “Darbepoetin alfa suppresses tumor necrosis factor-α-induced endothelin-1 production through antioxidant action in human aortic endothelial cells: role of sialic acid residues,” Free Radical Biology and Medicine, vol. 50, no. 10, pp. 1242–1251, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. W. S. Yang, J. M. Lee, N. J. Han, Y. J. Kim, J. W. Chang, and S. K. Park, “Mycophenolic acid attenuates tumor necrosis factor-α-induced endothelin-1 production in human aortic endothelial cells,” Atherosclerosis, vol. 211, no. 1, pp. 48–54, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. P. Chomczynski and N. Sacchi, “Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction,” Analytical Biochemistry, vol. 162, no. 1, pp. 156–159, 1987. View at Scopus
  30. K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2ΔΔCT method,” Methods, vol. 25, no. 4, pp. 402–408, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. V. C. Cogger, M. Muller, R. Fraser, A. J. McLean, J. Khan, and D. G. Le Couteur, “The effects of oxidative stress on the liver sieve,” Journal of Hepatology, vol. 41, no. 3, pp. 370–376, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. S. A. Keller, C. C. Moore, M. G. Clemens, I. H. McKillop, and T. Huynh, “Activated protein C restores hepatic microcirculation during sepsis by modulating vasoregulator expression,” Shock, vol. 36, no. 4, pp. 361–369, 2011. View at Publisher · View at Google Scholar
  33. M. Glanemann, B. Vollmar, A. K. Nussler, T. Schaefer, P. Neuhaus, and M. D. Menger, “Ischemic preconditioning protects from hepatic ischemia/reperfusion-injury by preservation of microcirculation and mitochondrial redox-state,” Journal of Hepatology, vol. 38, no. 1, pp. 59–66, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. M. J. Czaja, “Cell signaling in oxidative stress-induced liver injury,” Seminars in Liver Disease, vol. 27, no. 4, pp. 378–389, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. P. J. de Bleser, G. Xu, K. Rombouts, V. Rogiers, and A. Geerts, “Glutathione levels discriminate between oxidative stress and transforming growth factor-β signaling in activated rat hepatic stellate cells,” The Journal of Biological Chemistry, vol. 274, no. 48, pp. 33881–33887, 1999. View at Publisher · View at Google Scholar · View at Scopus
  36. L. S. Oliboni, C. Dani, C. Funchal, J. A. Henriques, and M. Salvador, “Hepatoprotective, cardioprotective, and renal-protective effects of organic and conventional grapevine leaf extracts on Wistar rat tissues,” Anais da Academia Brasileira de Ciências, vol. 83, no. 4, pp. 1403–1411, 2011. View at Publisher · View at Google Scholar
  37. J. L. Li, Q. Y. Wang, H. Y. Luan, Z. C. Kang, and C. B. Wang, “Effects of L-carnitine against oxidative stress in human hepatocytes: involvement of peroxisome proliferator-activated receptor α,” Journal of Biomedical Science, vol. 19, article 32, 2012. View at Publisher · View at Google Scholar
  38. S. A. Ganie, E. Haq, A. Hamid, A. Masood, and M. A. Zargar, “Long dose exposure of hydrogen peroxide (H2O2) in albino rats and effect of Podophyllum hexandrum on oxidative stress,” European Review for Medical and Pharmacological Sciences, vol. 15, no. 8, pp. 906–915, 2011.
  39. M. E. Anderson and A. Meister, “Glutathione monoesters,” Analytical Biochemistry, vol. 183, no. 1, pp. 16–20, 1989. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Y. Kim, E. H. Song, H. J. Lee et al., “HBx-Induced hepatic steatosis and apoptosis are regulated by TNFR1- and NF-κB-dependent pathways,” Journal of Molecular Biology, vol. 397, no. 4, pp. 917–931, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. C. H. Lee, S. H. Kim, and S. M. Lee, “Effect of pyrrolidine dithiocarbamate on hepatic vascular stress gene expression during ischemia and reperfusion,” European Journal of Pharmacology, vol. 595, no. 1–3, pp. 100–107, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Ohkita, M. Takaoka, Y. Shiota, R. Nojiri, M. Sugii, and Y. Matsumura, “A nuclear factor-κB inhibitor BAY 11-7082 suppresses endothelin-1 production in cultured vascular endothelial cells,” Japanese Journal of Pharmacology, vol. 89, no. 1, pp. 81–84, 2002. View at Publisher · View at Google Scholar · View at Scopus
  43. I. Sigala, P. Zacharatos, D. Toumpanakis et al., “MAPKs and NF-κB differentially regulate cytokine expression in the diaphragm in response to resistive breathing: the role of oxidative stress,” The American Journal of Physiology, vol. 300, no. 5, pp. R1152–R1162, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. E. S. Cho, S. B. Lee, I. H. Bae, Y. S. Lee, S. J. Lee, and H. D. Um, “Ionizing radiation induces blockade of c-Jun N-terminal kinase-dependent cell death pathway in a manner correlated with p21Cip/WAF1 induction in primary cultured normal human fibroblasts,” Experimental and Molecular Medicine, vol. 37, no. 4, pp. 282–289, 2005. View at Scopus
  45. S. J. Wort, M. Ito, P. C. Chou et al., “Synergistic induction of endothelin-1 by tumor necrosis factor α and interferon γ is due to enhanced NF-κB binding and histone acetylation at specific κB sites,” The Journal of Biological Chemistry, vol. 284, no. 36, pp. 24297–24305, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. C. Gallois, A. Habib, J. Tao et al., “Role of NF-κB in the antiproliferative effect of endothelin-1 and tumor necrosis factor-α in human hepatic stellate cells: involvement of cyclooxygenase-2,” The Journal of Biological Chemistry, vol. 273, no. 36, pp. 23183–23190, 1998. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Ghosh, M. J. May, and E. B. Kopp, “NF-κB and rel proteins: evolutionarily conserved mediators of immune responses,” Annual Review of Immunology, vol. 16, pp. 225–260, 1998. View at Publisher · View at Google Scholar · View at Scopus
  48. P. Calabrò, P. Cirillo, G. Limongelli et al., “Tissue factor is induced by resistin in human coronary artery endothelial cells by the NF-κB-dependent pathway,” Journal of Vascular Research, vol. 48, no. 1, pp. 59–66, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. M. L. Cho, Y. M. Moon, Y. J. Heo et al., “NF-κB inhibition leads to increased synthesis and secretion of MIF in human CD4+ T cells,” Immunology Letters, vol. 123, no. 1, pp. 21–30, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Zanotto-Filho, D. P. Gelain, R. Schröder et al., “The NFκB-mediated control of RS and JNK signaling in vitamin A-treated cells: duration of JNK-AP-1 pathway activation may determine cell death or proliferation,” Biochemical Pharmacology, vol. 77, no. 7, pp. 1291–1301, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. A. Kumar, G. Negi, and S. S. Sharma, “Suppression of NF-κB and NF-κB regulated oxidative stress and neuroinflammation by BAY 11-7082 (IkB phosphorylation inhibitor) in experimental diabetic neuropathy,” Biochimie, vol. 94, no. 5, pp. 1158–1165, 2012. View at Publisher · View at Google Scholar
  52. A. Q. Khan, R. Khan, W. Qamar et al., “Caffeic acid attenuates 12-O-tetradecanoyl-phorbol-13-acetate (TPA)-induced NF-κB and COX-2 expression in mouse skin: abrogation of oxidative stress, inflammatory responses and proinflammatory cytokine production,” Food and Chemical Toxicology, vol. 50, no. 2, pp. 175–183, 2012. View at Publisher · View at Google Scholar
  53. E. Chávez, L. Castro-Sánchez, M. Shibayama et al., “Effects of acetyl salicylic acid and ibuprofen in chronic liver damage induced by CCl4,” Journal of Applied Toxicology, vol. 32, no. 1, pp. 51–59, 2011. View at Publisher · View at Google Scholar
  54. A. Piechota and A. Goraca, “Influence of nuclear factor-κB inhibition on endothelin-1 induced lung edemaand oxidative stress in rats,” Journal of Physiology and Pharmacology, vol. 62, no. 2, pp. 183–188, 2011. View at Scopus
  55. A. Wullaert, G. van Loo, K. Heyninck, and R. Beyaert, “Hepatic tumor necrosis factor signaling and nuclear factor-κB: effects on liver homeostasis and beyond,” Endocrine Reviews, vol. 28, no. 4, pp. 365–386, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. M. Karin, “Nuclear factor-κB in cancer development and progression,” Nature, vol. 441, no. 7092, pp. 431–436, 2006.
  57. H. Nakagawa, Y. Hirata, K. Takeda et al., “Apoptosis signal-regulating kinase 1 inhibits hepatocarcinogenesis by controlling the tumor-suppressing function of stress-activated mitogen-activated protein kinase,” Hepatology, vol. 54, no. 1, pp. 185–195, 2011. View at Publisher · View at Google Scholar · View at Scopus